C4 Therapeutics, Inc. (CCCC)
3.87
+0.16
(+4.31%)
USD |
NASDAQ |
Sep 01, 16:00
3.865
0.00 (0.00%)
After-Hours: 20:00
C4 Therapeutics Total Long Term Debt (Quarterly) : 50.18M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.18M |
| March 31, 2026 | 51.92M |
| December 31, 2025 | 53.62M |
| September 30, 2025 | 55.25M |
| June 30, 2025 | 56.86M |
| March 31, 2025 | 58.45M |
| December 31, 2024 | 59.98M |
| September 30, 2024 | 61.46M |
| June 30, 2024 | 62.92M |
| March 31, 2024 | 64.36M |
| December 31, 2023 | 65.76M |
| September 30, 2023 | 67.10M |
| June 30, 2023 | 78.75M |
| March 31, 2023 | 80.63M |
| Date | Value |
|---|---|
| December 31, 2022 | 82.45M |
| September 30, 2022 | 83.48M |
| June 30, 2022 | 84.49M |
| March 31, 2022 | 85.70M |
| December 31, 2021 | 41.54M |
| September 30, 2021 | 21.51M |
| June 30, 2021 | 21.64M |
| March 31, 2021 | 21.76M |
| December 31, 2020 | 21.88M |
| September 30, 2020 | 21.97M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 12.87M |
| September 30, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 232.15M |
| Rallybio Corp. | 0.00 |
| Q32 Bio, Inc. | 4.561M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |